ObsEva (NASDAQ:OBSV) Receives New Coverage from Analysts at StockNews.com

StockNews.com began coverage on shares of ObsEva (NASDAQ:OBSV) in a research report released on Monday morning. The firm issued a hold rating on the stock.

ObsEva Stock Performance

NASDAQ:OBSV opened at $0.01 on Monday. The stock has a market capitalization of $389,855.00, a PE ratio of -0.01 and a beta of 0.68. ObsEva has a 1-year low of $0.08 and a 1-year high of $2.14. The firm has a fifty day simple moving average of $0.01 and a 200 day simple moving average of $0.04.

ObsEva Company Profile

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.